SITC 2023 Hybrid Group Meetings

Friday, November 3rd through Saturday, November 4th Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into (SITC) Society for Immunotherapy of Cancer 2023

    Friday, November 3rd
    12:00 PM ET (9:00 AM PT) - Jason Luke // Hybrid
    • IO/Melanoma | Associate Professor, University of Pittsburgh School of Medicine
    1:00 PM ET (10:00 AM PT) - Thomas Marron // Hybrid
    • IO/NSCLC | Associate Professor of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai
    2:00 PM ET (11:00 AM PT) - Yana Najjar // Hybrid
    • IO/Melanoma | Assistant Professor of Medicine, University of Pittsburgh Medical Center
    3:00 PM ET (12:00 PM PT) - Diwakar Davar // Hybrid
    • IO/PRAME | Assistant Professor of Phase I Therapeutics and Melanoma, UPMC Hillman Cancer Center
    Saturday, November 4th
    8:00 AM ET (11:00 AM PT) - Adil Daud // Hybrid
    • PRAME/IO | Director of Melanoma Clinical Research and Director of the Melanoma Program, The University of California at San Francisco
    1:00 PM ET (10:00 AM PT) - Adi Diab // Hybrid
    • Melanoma | Assistant Professor, The University of Texas MD Anderson Cancer Center
    2:00 PM ET (11:00 AM PT) - Joshua Brody // Hybrid
    • IO Hematologic Malignancies | Associate Professor in Hematology and Medical Oncology & Director of the Lymphoma Immunotherapy Program, Mount Sinai Medical Center Inc.
    3:00 PM ET (12:00 PM PT) - Tanguy Seiwert // Hybrid
    • Lung | Assistant Professor and Director of Head and Neck Oncology Disease Group, Johns Hopkins University
    4:00 PM ET (1:00 PM PT) - Patrick Forde // Virtual Only
    • Lung | Director of the Thoracic Oncology Research Program, Johns Hopkins School of Medicine

    *SITC Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.